Cargando…

Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes

Background: Human Vγ9Vδ2 γδ T cells can kill a variety of cancer cells and have attracted substantial interest for cancer immunotherapy. Toll-like receptor (TLR) ligands are promising adjuvants for cancer immunotherapy, but TLR7/8 ligand Resiquimod has been shown to inhibit CD4 T-cell activation in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serrano, Ruben, Wesch, Daniela, Kabelitz, Dieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140608/ https://www.ncbi.nlm.nih.gov/pubmed/32183240 http://dx.doi.org/10.3390/cells9030713

Ejemplares similares

Correction: Serrano, R.; Wesch, D.; Kabelitz, D. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes. Cells 2020, 9, 713
por: Serrano, Ruben, et al.
Publicado: (2020)

Monocyte-dependent co-stimulation of cytokine induction in human γδ T cells by TLR8 RNA ligands
por: Serrano, Ruben, et al.
Publicado: (2021)

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
por: Tawfik, Doaa, et al.
Publicado: (2019)

Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells
por: Peters, Christian, et al.
Publicado: (2013)

Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity
por: Kabelitz, Dieter, et al.
Publicado: (2013)

Stimulatory and inhibitory activity of STING ligands on tumor-reactive human gamma/delta T cells
por: Serrano, Ruben, et al.
Publicado: (2022)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins
por: Kabelitz, Dieter, et al.
Publicado: (2017)

Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity
por: Gonnermann, Daniel, et al.
Publicado: (2020)

Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
por: Chitadze, Guranda, et al.
Publicado: (2015)

Human γδ T lymphocytes for immunotherapeutic strategies against cancer
por: Kabelitz, Dieter
Publicado: (2010)

Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells
por: Jonescheit, Hannah, et al.
Publicado: (2020)

Vitamin C and Vitamin D—friends or foes in modulating γδ T-cell differentiation?
por: Peters, Christian, et al.
Publicado: (2022)

The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease
por: Kabelitz, Dieter
Publicado: (2023)

Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran
por: Kabelitz, Dieter
Publicado: (2020)

Reply to: Vitamin C as a promoter of γδ T cells
por: Kouakanou, Léonce, et al.
Publicado: (2021)

Tribody [(HER2)(2)xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
por: Oberg, Hans H., et al.
Publicado: (2018)

Toll-Like Receptors, Their Ligands, and Atherosclerosis
por: Hodgkinson, Conrad P., et al.
Publicado: (2011)

Editorial: γδ T Cells in Cancer
por: Coffelt, Seth B., et al.
Publicado: (2020)

Analysis of the Seasonal Fluctuation of γδ T Cells and Its Potential Relation with Vitamin D(3)
por: Bernicke, Birthe, et al.
Publicado: (2022)

Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells
por: Law, Helen KW, et al.
Publicado: (2009)

Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
por: Guriec, Nathalie, et al.
Publicado: (2018)

Signal strength of STING activation determines cytokine plasticity and cell death in human monocytes
por: Kabelitz, Dieter, et al.
Publicado: (2022)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands
por: Barbalat, Roman, et al.
Publicado: (2009)

Differential Constitutive and Cytokine-Modulated Expression of Human Toll-like Receptors in Primary Neutrophils, Monocytes, and Macrophages
por: O'Mahony, D. Shane, et al.
Publicado: (2008)

Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells
por: Oberg, Hans-Heinrich, et al.
Publicado: (2019)

Vitamin C promotes the proliferation and effector functions of human γδ T cells
por: Kouakanou, Léonce, et al.
Publicado: (2019)

Immunoregulation effects of different γδT cells and toll-like receptor signaling pathways in neonatal necrotizing enterocolitis
por: Hui, Lei, et al.
Publicado: (2017)

Anti-CD3 Fab Fragments Enhance Tumor Killing by Human γδ T Cells Independent of Nck Recruitment to the γδ T Cell Antigen Receptor
por: Juraske, Claudia, et al.
Publicado: (2018)

Endogenous toll-like receptor ligands and their biological significance
por: Yu, Li, et al.
Publicado: (2010)

Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
por: Gurley, Catherine, et al.
Publicado: (2008)

Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands
por: Rostamizadeh, Leila, et al.
Publicado: (2022)

Monocyte Subpopulations from Pre-Eclamptic Patients Are Abnormally Skewed and Exhibit Exaggerated Responses to Toll-Like Receptor Ligands
por: Al-ofi, Ebtisam, et al.
Publicado: (2012)

Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
por: Patinote, Cindy, et al.
Publicado: (2020)

γδ T cells: origin and fate, subsets, diseases and immunotherapy
por: Hu, Yi, et al.
Publicado: (2023)

Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More
por: Herrmann, Thomas, et al.
Publicado: (2022)

The role of Toll‐like receptor 10 in modulation of trained immunity
por: Mourits, Vera P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a51rp7epdm9ps8akhndmorkadu